HOME » ATROPEN® AUTO-INJECTORS

AtroPen® Auto-Injectors

AtroPen® 2 mg Auto-Injector (atropine injection)

  • NDC: 11704-106-01
  • Indication: Antidote for organophosphorous (nerve agent/insecticide) poisoning
  • Delivers: 2 mg atropine sulfate equivalent in 0.7 mL
  • Packaged: 12 single pack auto-injectors/box
  • Package Insert


AtroPen® 1 mg Auto-Injector (atropine injection)

  • NDC: 11704-105-01
  • Indication: Antidote for organophosphorous (nerve agent/insecticide) poisoning
  • Delivers: 1 mg atropine sulfate equivalent in 0.7 mL
  • Packaged: 12 single pack auto-injectors/box
  • Package Insert


AtroPen® 0.5 mg Auto-Injector (atropine injection)

  • NDC: 11704-104-01
  • Indication: Antidote for organophosphorous (nerve agent/insecticide) poisoning
  • Delivers: 0.5 mg atropine sulfate equivalent in 0.7 mL
  • Packaged: 12 single pack auto-injectors/box
  • Package Insert


AtroPen® 0.25 mg Auto-Injector (atropine injection)

  • NDC: 11704-107-01
  • Indication: Antidote for organophosphorous (nerve agent/insecticide) poisoning
  • Delivers: 0.25 mg atropine sulfate equivalent in 0.3 mL
  • Packaged: 12 single pack auto-injectors/box
  • Package Insert

AtroPen® is a registered trademark of Meridian Medical Technologies™, Inc. in the United States of America.


IMPORTANT SAFETY INFORMATION: Primary protection against exposure to chemical nerve agents and insecticide poisoning is the wearing of protective garments including masks designed specifically for this use. Individuals should not rely solely upon antidotes such as atropine and pralidoxime to provide complete protection from chemical nerve agents and insecticide poisoning. Seek immediate medical attention after injection with antidotes.

PN MMT3705 © 2007 Meridian Medical Technologies™, Inc. a subsidiary of King Pharmaceuticals®, Inc.